Should the pT2 tumor classification for renal cell carcinoma be subdivided according to tumor size?
Hein Van Poppel
Correspondence Department of Urology, University Hospital K. U. Leuven, B-3000 Leuven, Belgium
Email hendrik.vanpoppel@uz.kuleuven.ac.be
This article has no abstract so we have provided the first paragraph of the full text.
Unlike a decade ago, we now know that RCC is not a single disease. Biological and clinical properties define a number of RCC subtypes with different clinical outcomes and responses to therapy. For example, patients with a chromophobe tumor have a better prognosis than patients with papillary type II or clear cell type RCC. In addition to histological subtype, multicentricity or bilaterality, presence of necrosis or sarcomatoid features, and Fuhrman grade all affect prognosis in patients with RCC.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.